MoonLake Immunotherapeutics

MoonLake Reports Positive Phase 3 PsA Results for Sonelokimab

ZUG, Switzerland, August 10, 2026 MoonLake Immunotherapeutics announced positive topline results from its Phase 3 IZAR-1 trial evaluating investigational...

By cGxPwire Editor
August 11, 2026

.Clinical

MoonLake Reports Strong Phase 3 Sonelokimab HS Results

ZUG, Switzerland, June 21, 2026 MoonLake Immunotherapeutics has announced compelling Week 52 results from its Phase 3 VELA clinical...

By cGxPwire Editor
June 23, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

MoonLake Immunotherapeutics

MoonLake Reports Positive Phase 3 PsA Results for Sonelokimab

MoonLake Reports Strong Phase 3 Sonelokimab HS Results